Board Moves.

3M (NYSE: MMM)

Promotes William Brown to Chair of the Board and appoints David Bozeman to the Board of Directors. Mr. Brown is the Chief Executive Officer at 3M and Mr. Bozeman is the Chief Executive Officer at CH Robinson.

AbbVie (NYSE: ABBV)

Robert Michael promoted to Chair of the Board continues as Chief Executive Officer. Mr. Michael is the former Division Controller, Abbott Nutrition Supply Chain at Abbott.

Altimmune (NASDAQ: ALT)

Appoints Teri Lawver and Jerome Durso to the Board of Directors. Ms.Lawver is the former Chief Commercial Officer at Dexcom and Mr. Durso is the former Chief Executive Officer at Intercept Pharma.

Altria Grp (NYSE: MO)

Appoints Richard Stoddart to the Board of Directors. Mr. Stoddart is the former Chief Executive Officer at InnerWorkings.

Arcus Biosciences (NYSE: RCUS)

Appoints Dietmar Berger to the Board of Directors. Mr. Berger is the Chief Medical Officer at Gilead Sciences.

Arrowhead Pharmaceuticals (NASDAQ: ARWR)

Appoints Douglas Ingram to the Board of Directors. Mr. Ingram is the Chief Executive Officer at Sarepta.

Atea Pharmaceuticals (NASDAQ: AVIR)

Appoints Arthur Kirsch to the Board of Directors. Mr. Kirsch is a Senior Advisor Alvarez & Marsal’s Life Sciences Industry Group.

Baxter Int’l (NYSE: BAX)

Brent Shafer promoted to Chair of the Board and Interim- Chief Executive Officer. Mr. Shafer is the former chairman and CEO of Cerner Corporation.

Bio-Techne (NASDAQ: TECH)

Appoints Amy Herr to the Board of Directors. Ms. Herr is a Professor of Bioengineering at UC Berkeley and Vice President at CZ Biohub Network.

BioMarin Pharmaceutical (NASDAQ: BMRN)

Appoints Timothy Walbert to the Board of Directors. Mr. Walbert is the former Founder and Chief Executive Officer at Horizon Therapeutics.

biote (NASDAQ: BTMD)

Bret Christensen named CEO and he is appointed to the Board of Directors. Mr. Christensen is the former Chief Executive Officer at DermTech.

Centene (NYSE: CNC)

Appoints Kenneth Tanji to the Board of Directors. Mr. Tanji is the former Chief Financial Officer at Prudential Financial.

Collegium Pharmaceutical (NASDAQ: COLL)

Appoints Nancy Lurker to the Board of Directors. Ms. Lurker is the former Chief Executive Officer at EyePoint Pharmaceuticals.

Conmed (NYSE: CNMD)

Appoints Mark Kaye to the Board of Directors. Mr. Kaye is the Chief Financial Officer at Elevance Health.

Cytokinetics (NASDAQ: CYTK)

Appoints Robert Landry to the Board of Directors. Mr. Landry is the former Chief Financial Officer at Regeneron Pharmaceuticals.

Dentsply Sirona (NASDAQ: XRAY)

Appoints Michael Barber and Daniel Scavilla to the Board of Directors.Mr. Barber is the former Chief Diversity Officer at General Electric and Mr. Scavilla is the Chief Executive Officer at Globus Medical.

DiaMedica Therapeutics (NASDAQ: DMAC)

Appoints Daniel O’Connor to the Board of Directors. Mr. O’Connor is the former Chief Executive Officer at Ambrx Biopharma.

Dynavax Technologies (NASDAQ: DVAX)

Appoints Lauren Silvernail and Emilio Emini to the Board of Directors. Ms.Silvernail is the former Chief Financial Officer at Evolus and Mr. Emini is the former Chief Executive Officer at Bill & Melinda Gates Medical Research Institute.

Fortrea (NASDAQ: FTRE)

Appoints Erin Russell to the Board of Directors. Ms. Russell is a former Principal at Vestar Capital.

Henry Schein (NASDAQ: HSIC)

Appoints Max Lin and William Daniel to the Board of Directors. Mr. Lin is a partner at KKR and Mr. Daniel is an executive advisor at KKR.

Inhibikase Therapeutics (NASDAQ: IKT)

Mark Iwicki named CEO and he is appointed to the Board of Directors. Mr.Iwicki is the former Chief Executive Officer at KALA BIO.Lantheus (NASDAQ: LNTH)Appoints Phuong Khanh to the Board of Directors. Ms. Khanh is the Senior Vice President and Head of Oncology Therapeutic Area Unit at Takeda.

Monopar Therapeutics (NASDAQ: MNPR)

Appoints Lavina Talukdar to the Board of Directors. Ms. Talukdar is the Senior Vice President, Head Investor Relations at Moderna.

Myriad Genetics (NASDAQ: MYGN)

Samraat Raha promoted to CEO and he is appointed to the Board of Directors. Mr. Raha is the former President, Diagnostics and Genomics Group | Senior Vice President, Agilent at Agilent Technologies.

Nature’s Sunshine Products (NASDAQ: NATR)

Appoints Katie May to the Board of Directors. Ms. May is the former Chief Executive Officer at ShippingEasy.

Orchestra BioMed (NASDAQ: OBIO)

Appoints Chris Cleary to the Board of Directors. Mr. Cleary is the Chief Executive Officer at Biomergence Capital.

Pacira BioSciences (NASDAQ: PCRX)

Promotes Laura Brege to Chair of the Board. Ms. Brege is the former CEO at Nodality.

Tectonic Therapeutic (NASDAQ: TECX)

Appoints Thomas Henley to the Board of Directors. Mr. Henley is a Managing Director at Bernhard Capital Partners.

Terns Pharmaceuticals (NASDAQ: TERN)

Appoints Robert Azelby to the Board of Directors. Mr. Azelby is the former Chief Executive Officer at Eliem Therapeutics.

TriSalus Life Sciences (NASDAQ: TLSI)

Appoints William Valle and Gary Gordon to the Board of Directors. Mr.Valle is the former Chief Executive Officer North America at Fresenius Medical Care and Mr. Gordon is the former President at Global Coalition for Adaptive Research.

Tyra Biosciences (NASDAQ: TYRA)

Appoints Adele Gulfo to the Board of Directors. Ms. Gulfo is the former Chief Executive Officer, Biopharma Commercial at Sumitomo Pharma America.

Zimmer Biomet (NYSE: ZBH)

Ivan Tornos promoted to Chair of the Board. Mr. Tornos is the Worldwide President at Becton Dickinson.

Zymeworks (NASDAQ: ZYME)

Appoints Oleg Nodelman and Scott Platshon to the Board of Directors. Mr.Nodelman is the Founder and Portfolio Manager at EcoR1 Capital and Mr.Platshon is a Partner at EcoR1.

‍

‍

‍

‍

Agios Pharmaceuticals (NASDAQ: AGIO)

David Schenkein leaves the Board of Directors. Mr. Schenkein is a General Partner and Co-Head Life Science at Google Ventures.

Boston Scientific (NYSE: BSX)

Charles Dockendorff to leave the Board of Directors. Mr. Dockendorff is the former Chief Financial Officer at Covidien plc.

Cooper Companies (NASDAQ: COO)

William Kozy retires from the Board of Directors. Mr. Kozy is the former Chief Operating Officer at Becton Dickinson.

Halozyme Therapeutics (NASDAQ: HALO)

Connie Matsui to leave the Board of Directors. Ms. Matsui is the former EVP - Knowledge and Innovation Networks at Biogen Idec.

IDEXX Laboratories (NASDAQ: IDXX)

Asha Collins resigns from the Board of Directors. Ms. Collins is the Senior Vice President and General Manager at Biobanks DNAnexus.

Immunitybio (NASDAQ: IBRX)

John Owen Brennan resigns from the Board of Directors. Mr. Brennan is former CIA.

Insmed (NASDAQ: INSM)

Alfred Altomari to leave the Board of Directors. Mr. Altomari is the former Chief Executive Officer at Agile Therapeutics.

Masimo (NASDAQ: MASI)

Robert Chapek resigns from the Board of Directors. Mr. Chapek is the former Chief Executive Officer at Disney.

McCormick & Company (NYSE: MKC)

Patricia Little retires from the Board of Directors. Ms. Little is the former Chief Financial Officer at Hershey.

Nuvation Bio (NYSE: NUVB)

Jerry Wang resigns from the Board of Directors. Mr. Wang is the former Head of Global Biostatistics, Epi, and Medical Writing (GBEM) China at Merck Serono

Perrigo plc (NYSE: PRGO)

Katherine Doyle to leave the Board of Directors. Ms. Doyle is the former Chief Executive Officer at Swanson Health Products.

Stryker (NYSE: SYK)

Allan Golston to leave the Board of Directors. Mr. Golston is the President, United States Program at Bill & Melinda Gates Foundation.